Cerevel Therapeutics Holdings, Inc. (CERE)

Sector:
FINANCE
Industry:
CORPORATE FINANCE
SIC:
PHARMACEUTICAL PREPARATIONS
222 JACOBS STREET CAMBRIDGE, MA 02141

Cerevel Therapeutics is dedicated to unraveling the mysteries of the brain to treat neuroscience diseases. The company is tackling neuroscience diseases with a differentiated approach that combines expertise in neurocircuitry with a focus on receptor selectivity. Cerevel Therapeutics has a diversified pipeline comprising five clinical-stage investigational therapies and several pre-clinical compounds with the potential to treat a range of neuroscience diseases, including Parkinson's, epilepsy, schizophrenia and substance use disorder. Headquartered in Cambridge, Mass., Cerevel Therapeutics is advancing its current research and development programs while exploring new modalities through internal research efforts, external collaborations or potential acquisitions.

Are you looking for this stock instead?

View SEC Filings from CERE instead.

View recent insider trading info

Cerevel Therapeutics Holdings, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CERE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CERE

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

100 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

100 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

COLES N ANTHONY CEO AND CHAIRPERSON

  • Officer
  • Director
 3,005,121 2023-01-05 3

RENGER JOHN CHIEF SCIENTIFIC OFFICER

  • Officer
 167,765 2022-11-01 7

PF EQUITY HOLDINGS 1 B.V.

  • 10% Owner
 0 2022-03-31 1

DIPIETRO KENNETH CHIEF HUMAN RESOURCES OFFICER

  • Officer
 75,985 2022-02-09 1

CEESAY ABRAHAM PRESIDENT

  • Officer
 120,310 2022-02-09 1

AKAMINE SCOTT CHIEF LEGAL OFFICER

  • Officer
 58,572 2022-02-09 1

SANCHEZ RAMIRO CHIEF MEDICAL OFFICER

  • Officer
 168,856 2022-02-09 1

BODENRADER MARK SEE REMARKS

  • Officer
 24,800 2022-02-09 1

TREGONING KATHLEEN SEE REMARKS

  • Officer
 63,321 2022-02-09 1

RIEDEL NORBERT G

  • Director
 42,810 2022-01-04 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • Director
 5,086,727 2021-08-26 0

SULZBERGER GABRIELLE

  • Director
 63,894 2021-06-24 0

DEKKERS MARIJN E

  • Director
 58,003 2021-06-10 0

GIORDANO DOUGLAS E.

  • Director
 58,003 2021-06-10 0

GORDON CHRISTOPHER R

  • Director
  • 10% Owner
 42,950 2021-06-10 0

KOPPEL ADAM

  • Director
  • 10% Owner
 42,950 2021-06-10 0

BAIN CAPITAL INVESTORS LLC

BC PERCEPTION HOLDINGS, LP

BCPE PERCEPTION GP, LLC

BAIN CAPITAL FUND XII, LP

BAIN CAPITAL PARTNERS XII, LLC

  • 10% Owner
 60,632,356 2020-11-09 0

AMBERGATE TRUST

LYNDA DE LOGI TRUST

SMITH DANA C

ROTHSCHILD TRUST GUERNSEY LTD (AMBERGATE)

  • 10% Owner
 2,811,366 2013-01-16 0

CARLSON ROBERT W JR.

  • SEE REMARKS
 No longer subject to file 2012-05-24 0

ARTAL LUXEMBOURG S A

ARTAL INTERNATIONAL SCA

ARTAL GROUP S A

WESTEND SA

STICHTING ADMINISTRATIEKANTOOR WESTEND

  • 10% Owner
 4,056,935 2012-02-27 0

AMBERGATE TRUST

LYNDA DE LOGI TRUST

ROTHSCHILD TRUST GUERNSEY LTD (AMBERGATE)

CARLSON ROBERT W JR.

SMITH DANA C

  • 10% Owner
 2,511,366 2012-02-27 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

COLES N ANTHONY - Director - Officer CEO AND CHAIRPERSON

2023-01-06 17:04:19 -0500 2023-01-05 M 50,000 $3.50 a 52,704 direct yes

COLES N ANTHONY - Director - Officer CEO AND CHAIRPERSON

2023-01-06 17:04:19 -0500 2023-01-05 S 49,500 $29.93 d 3,204 direct yes

COLES N ANTHONY - Director - Officer CEO AND CHAIRPERSON

2023-01-06 17:04:19 -0500 2023-01-05 S 500 $30.73 d 2,704 direct yes

COLES N ANTHONY - Director - Officer CEO AND CHAIRPERSON

2023-01-06 17:04:19 -0500 2023-01-05 M 50,000 d 3,002,417 direct yes

COLES N ANTHONY - Director - Officer CEO AND CHAIRPERSON

2022-12-13 16:44:18 -0500 2022-12-09 M 50,000 $3.50 a 52,704 direct yes

COLES N ANTHONY - Director - Officer CEO AND CHAIRPERSON

2022-12-13 16:44:18 -0500 2022-12-09 S 44,855 $26.62 d 7,849 direct yes

COLES N ANTHONY - Director - Officer CEO AND CHAIRPERSON

2022-12-13 16:44:18 -0500 2022-12-09 S 5,145 $27.09 d 2,704 direct yes

COLES N ANTHONY - Director - Officer CEO AND CHAIRPERSON

2022-12-13 16:44:18 -0500 2022-12-09 M 50,000 d 3,052,417 direct yes

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 22:15:03 UTC 4.0238 0.2962 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 21:45:04 UTC 4.0238 0.2962 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 21:15:04 UTC 4.0238 0.2962 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 20:45:03 UTC 4.0258 0.2942 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 20:15:04 UTC 4.0258 0.2942 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 19:45:03 UTC 4.0258 0.2942 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 19:15:03 UTC 4.0258 0.2942 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 18:45:04 UTC 4.0409 0.2791 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 18:15:03 UTC 4.0409 0.2791 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 17:45:03 UTC 4.0409 0.2791 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 17:15:04 UTC 4.0409 0.2791 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 16:45:03 UTC 4.0555 0.2645 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 16:15:03 UTC 4.0555 0.2645 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 15:45:03 UTC 4.0555 0.2645 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 15:15:04 UTC 4.0555 0.2645 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 14:45:04 UTC 4.0555 0.2645 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 14:15:03 UTC 4.0555 0.2645 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 13:45:03 UTC 4.0052 0.3148 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 13:15:03 UTC 4.0052 0.3148 450000
CEREVEL THERAPEUTICS HOLDING CERE 2023-01-27 12:45:03 UTC 4.0052 0.3148 450000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund CERE -1156.0 shares, $-33639.6 2022-08-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund CERE -1900.0 shares, $-53694.0 2022-09-30 N-PORT
Guidestone Funds- Strategic Alternatives Fund CERE -1386.0 shares, $-39168.36 2022-09-30 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund CERE -2576.0 shares, $-72797.76 2022-09-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund CERE -227.0 shares, $-6415.02 2022-09-30 N-PORT
JNL Series Trust- JNL Multi-Manager Alternative Fund CERE -1830.0 shares, $-51715.8 2022-09-30 N-PORT
LAZARD FUNDS INC- Lazard Enhanced Opportunities Portfolio CERE -540.0 shares, $-15260.4 2022-09-30 N-PORT
VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND CERE -71920.0 shares, $-2032459.2 2022-09-30 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund CERE -3038.0 shares, $-84942.48 2022-10-31 N-PORT

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

Elevate your investments